...covering use of the product in adults in 1Q08. Alta was an early investor in Corgentech...

...responsible for all the costs associated with regulatory, distribution, marketing and selling activities. ANSV (formerly Corgentech Inc....

...be called Wanbang/Anesiva (Jiangsu) Pharmaceuticals Ltd. and will be located in XuZhou, China. ANSV (formerly Corgentech Inc....

...covering use of the product in adults by the end of the year. ANSV (formerly Corgentech...

...venous access procedures in children. The NDA will receive a standard 10-month review. ANSV (formerly Corgentech...

...on Nov. 22, 2006, and will be subject to a standard 10-month review. ANSV (formerly Corgentech...

...NDA was submitted on Nov. 22 and will receive a standard 10-month review. ANSV (formerly Corgentech...

...for Zingo (3268) to treat pain associated with venous access procedures in children. ANSV (formerly Corgentech...

...3268) to treat pain associated with venous access procedures in children. ANSV (formerly known as Corgentech...

...The shares were sold from an existing shelf registration. ANSV, which was formerly known as Corgentech...